Clinical trial
A Randomized, Double-blind, Single-dose, 2-Period, Crossover Study to Assess the Efficacy of PT027 Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult and Adolescent Subjects With Asthma
NCT04234464 is registered in ClinicalTrials.gov with Bond Avillion 2 Development LP as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Single-dose, 2-Period, Crossover Study to Assess the Efficacy of PT027 Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult and Adolescent Subjects With Asthma
- Lead sponsor
- Bond Avillion 2 Development LP
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 15, 2020
- Completion date
- August 28, 2020
- Enrollment
- 60 (actual)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
exercise induced bronchospasm